Dr. Justin Gainor is the director of the Center for Thoracic Cancers at the Massachusetts General Hospital and Director of Targeted Immunotherapy in the Henri and Belinda Termeer Center for Targeted Therapies. He focuses on the design of clinical trials evaluating novel therapeutics for molecularly-defined subsets of non-small cell lung cancer. In parallel, he is interested in translational research questions with an emphasis on understanding the molecular mechanisms of resistance to targeted therapies.